Filing Details

Accession Number:
0001209191-21-010411
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-12 18:53:42
Reporting Period:
2021-02-11
Accepted Time:
2021-02-12 18:53:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. ATRS Surgical & Medical Instruments & Apparatus (3841) 411350192
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1275012 J Thomas Garrity C/O Antares Pharma, Inc.
100 Princeton South, Suite 300
Ewing NJ 08628
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-11 50,000 $1.12 274,406 No 4 M Direct
Common Stock Disposition 2021-02-11 50,000 $4.62 224,406 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-02-11 50,000 $0.00 50,000 $1.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-06-02 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  2. The options vested and became exercisable in four equal quarterly installments from the grant date of June 2, 2016.